Xeris Pharmaceuticals' Series B Round

Xeris Pharmaceuticals raised a round of funding on January 07, 2015. Investors include Central Texas Angel Network.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' Series B Round: